Pia Keinicke Fabricius

Mrs. Pia Keinicke Fabricius

Hvidovre Hospital, Hvidovre, Denmark
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2021 in Metabolites
Verified
Journal Article
Open access
PDF file
AAAnissa Aharaz
Anissa Aharaz
JRJens Henning Rasmussen
Jens Henning Rasmussen
HMHelle Bach Ølgaard McNulty
Helle Bach Ølgaard McNulty
ACArne Cyron
Arne Cyron
PFPia Keinicke Fabricius
Pia Keinicke Fabricius
MHMorten Baltzer Houlind
Morten Baltzer Houlind
Medication deprescribing is essential to prevent inappropriate medication use in multimorbid patients. However, experience of deprescribing in Danish Subacute Medical Outpatient Clinics (SMOCs) is limited. The objective of our pilot study was to evaluate the feasibility and sustainability of a collaborative deprescribing intervention by a pharmacist and a physician to multimorbid patients in a SMOC. A randomized controlled pilot study was conducted, with phone follow-up at 30 and 365+ days. A senior pharmacist performed a systematic deprescribing intervention using the Screening Tool of Older Persons’ potentially inappropriate Prescriptions (STOPP) criteria, the Danish deprescribing list, and patient interviews. A senior physician received the proposed recommendations and decided which should be implemented. The main outcome was the number of patients having ≥1 medication where deprescribing status was sustained 30 days after inclusion. Out of 76 eligible patients, 72 (95%) were included and 67 (93%) completed the study (57% male; mean age 73 years; mean number of 10 prescribed medications). Nineteen patients (56%) in the intervention group and four (12%) in the control group had ≥1 medication where deprescribing status was sustained 30 days after inclusion (p = 0.015). In total, 37 medications were deprescribed in the intervention group and five in the control group. At 365+ days after inclusion, 97% and 100% of the deprescribed medications were sustained in the intervention and control groups, respectively. The three most frequently deprescribed medication groups were analgesics, cardiovascular, and gastrointestinal medications. In conclusion, a collaborative deprescribing intervention for multimorbid patients was feasible and resulted in sustainable deprescribing of medication in a SMOC.


30 December 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PFPia Keinicke Fabricius
Pia Keinicke Fabricius
OAOve Andersen
Ove Andersen
KSKarina Dahl Steffensen
Karina Dahl Steffensen
JKJeanette Wassar Kirk
Jeanette Wassar Kirk
Background: More than 70% of patients admitted to emergency departments (EDs) in Denmark are older patients with multimorbidity and polypharmacy vulnerable to adverse events and poor outcomes. Research suggests that patient involvement and shared decision-making (SDM) could optimize the treatment of older patients with polypharmacy. The patients become more aware of potential outcomes and, therefore, often tend to choose less medication. However, implementing SDM in clinical practice is challenging if it does not fit into existing workflows and healthcare systems.Aim: The aim was to explore the determinants of patient involvement in decisions made in the ED about the patient’s medication.Methods: The design was a qualitative ethnographic study. We observed forty-eight multidisciplinary healthcare professionals in two medical EDs focusing on medication processes and patient involvement in medication. Based on field notes, we developed a semi-structured interview guide. We conducted 20 semi-structured interviews with healthcare professionals to elaborate on the findings. Data were analyzed with thematic analyses.Findings: We found five themes (determinants) which affected patient involvement in decisions about medicine in the ED: 1) blurred roles among multidisciplinary healthcare professionals, 2) older patients with polypharmacy increase complexity, 3) time pressure, 4) faulty IT- systems, and 5) the medicine list as a missed enabler of patient involvement.Conclusion: There are several barriers to patient involvement in decisions about medicine in the ED and some facilitators. A tailored medication conversation guide based on the SDM methodology combined with the patient’s printed medicine list and well-functioning IT- systems can function as a boundary object, ensuring the treatment is optimized and aligned with the patient’s preferences and goals.

PFPia Keinicke Fabricius
Pia Keinicke Fabricius
AAAnissa Aharaz
Anissa Aharaz
NSNina Thórný Stefánsdóttir
Nina Thórný Stefánsdóttir
MHMorten Baltzer Houlind
Morten Baltzer Houlind
KSKarina Dahl Steffensen
Karina Dahl Steffensen
JKJeanette Wassar Kirk
Jeanette Wassar Kirk
Shared decision making (SDM) about medicine with older poly-medicated patients is vital to improving adherence and preventing medication-related hospital admissions, but it is difficult to achieve in practice. This study’s primary aim was to provide insight into the extent of SDM in medication decisions in the Emergency Department (ED) and to compare how it aligns with older poly-medicated patients’ preferences and needs. We applied a mixed-methods design to investigate SDM in medication decisions from two perspectives: (1) observational measurements with the observing patient involvement (OPTION 5) instrument of healthcare professionals’ SDM behavior in medication decisions and (2) semi-structured interviews with older poly-medicated patients. A convergent parallel analysis was performed. Sixty-five observations and fourteen interviews revealed four overall themes: (1) a low degree of SDM about medication, (2) a variation in the pro-active and non-active patients approach to conversations about medicine, (3) no information on side effects, and (4) a preference for medication reduction. The lack of SDM with older patients in the ED may increase inequality in health. Patients with low health literacy are at risk of safety threats, nonadherence, and preventable re-admissions. Therefore, healthcare professionals should systematically investigate older poly-medicated patients’ preferences and discuss the side effects and the possibility of reducing harmful medicine.

6 July 2026 in International Journal of Nursing Studies
Verified
Journal Article
Open access
JFJeanette Finderup
Jeanette Finderup
HEHelle Sorensen von Essen
Helle Sorensen von Essen
BBBirte Berger-Höger
Birte Berger-Höger
LBLouise Engelbrecht Buur
Louise Engelbrecht Buur
PFPia Keinicke Fabricius
Pia Keinicke Fabricius
DSDawn Stacey
Dawn Stacey
Shared decision making has gained increasing attention as part of person-centred care. However, research on shared decision making has largely focused on physician-patient interactions, and little is known about nurse-led shared decision making between nurses and patients. To identify and synthesise empirical evidence on nurse-led shared decision making with patients or families, examining: 1) contexts and decision types, 2) intervention components, 3) reported outcomes and experiences, and 4) guiding frameworks. A scoping review was conducted following Arksey and O'Malley. MEDLINE, CINAHL, and Scopus were searched, supplemented by citation tracking to March 2026. Included citations were empirical studies describing shared decision making occurring directly between a nurse and a patient or family member. Screening and data extraction were conducted independently by two researchers. Findings were synthesised descriptively and as part of the final stage of the review, findings were reviewed and verified through consultation with experts. Of 19,215 citations identified, 23 publications of 22 studies were eligible. Nurse-led shared decision making occurred in the clinical contexts of nephrology, oncology, primary care, psychiatry, rehabilitation, neonatal, home care, and hospice. The types of decision included major treatment decisions and everyday nursing care decisions. Interventions were shared decision making training, structured consultations (e.g. specific stages or steps of interactions), and decision support (e.g., patient decision aids, decision coaching), and some studies additionally included implementation supports. Nurse-led shared decision making increased patient involvement in decision making, perceived empowerment, satisfaction with shared decision making and treatment, self-confidence in decision making, and adherence to treatment. Common barriers to nurse-led shared decision making included time constraints and lack of organisational support. Of 15 studies citing shared decision making frameworks, one was nursing-specific: King's Goal Attainment Theory and one was interprofessional: Interprofessional Shared Decision-Making Model. The limited evidence on nurse-led shared decision making spans diverse clinical contexts and uses various interventions. Future research of nurse-led shared decision making interventions should improve the consistency and reporting of intervention components, and examine how these interventions can be implemented in clinical nursing practice.